Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014

Guillermo Dominguez-Cherit, Alethse De La Torre, Asgar Rishu, Ruxandra Pinto, Silvio A. Ñamendys-Silva, Adrián Camacho-Ortiz, Marco Antonio Silva-Medina, Carmen Hernández-Cárdenas, Michel Martínez-Franco, Alejandro Quesada-Sánchez, Guadalupe Celia López-Gallegos, Juan L. Mosqueda-Gómez, Norma E. Rivera-Martinez, Fernando Campos-Calderón, Eduardo Rivero-Sigarroa, Thierry Hernández-Gilsoul, Lourdes Espinosa-Pérez, Alejandro E. Macías, Dolores M. Lue-Martínez, Christian Buelna-CanoAna Sofía Ramírez-García Luna, Nestor G. Cruz-Ruiz, Manuel Poblano-Morales, Fernando Molinar-Ramos, Martin Hernandez-Torre, Marco Antonio León-Gutiérrez, Oscar Rosaldo-Abundis, José Ángel Baltazar-Torres, Henry T. Stelfox, Bruce Light, Philippe Jouvet, Steve Reynolds, Richard Hall, Nikki Shindo, Nick Daneman, Robert A. Fowler

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

22 Citas (Scopus)

Resumen

Objectives: The 2009-2010 influenza A (H1N1pdm09) pandemic caused substantial morbidity and mortality among young patients; however, mortality estimates have been confounded by regional differences in eligibility criteria and inclusion of selected populations. In 2013-2014, H1N1pdm09 became North America's dominant seasonal influenza strain. Our objective was to compare the baseline characteristics, resources, and treatments with outcomes among critically ill patients with influenza A (H1N1pdm09) in Mexican and Canadian hospitals in 2014 using consistent eligibility criteria. Design: Observational study and a survey of available healthcare setting resources. Setting: Twenty-one hospitals, 13 in Mexico and eight in Canada. Patients: Critically ill patients with confirmed H1N1pdm09 during 2013-2014 influenza season. Interventions: None. Measurements and Main Results: The main outcome measures were 90-day mortality and independent predictors of mortality. Among 165 adult patients with H1N1pdm09-related critical illness between September 2013 and March 2014, mean age was 48.3 years, 64% were males, and nearly all influenza was community acquired. Patients were severely hypoxic (median Pao 2 -to-Fio 2 ratio, 83 mm Hg), 97% received mechanical ventilation, with mean positive end-expiratory pressure of 14 cm H 2 O at the onset of critical illness and 26.7% received rescue oxygenation therapy with prone ventilation, extracorporeal life support, high-frequency oscillatory ventilation, or inhaled nitric oxide. At 90 days, mortality was 34.6% (13.9% in Canada vs 50.5% in Mexico, p < 0.0001). Independent predictors of mortality included lower presenting Pao 2 -to-Fio 2 ratio (odds ratio, 0.89 per 10-point increase [95% CI, 0.80-0.99]), age (odds ratio, 1.49 per 10 yr increment [95% CI, 1.10-2.02]), and requiring critical care in Mexico (odds ratio, 7.76 [95% CI, 2.02-27.35]). ICUs in Canada generally had more beds, ventilators, healthcare personnel, and rescue oxygenation therapies. Conclusions: Influenza A (H1N1pdm09)-related critical illness still predominantly affects relatively young to middle-aged patients and is associated with severe hypoxemic respiratory failure. The local critical care system and available resources may be influential determinants of patient outcome.

Idioma originalEnglish
Páginas (desde-hasta)1861-1870
Número de páginas10
PublicaciónCritical Care Medicine
Volumen44
N.º10
DOI
EstadoPublished - oct. 1 2016
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
Copyright © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

ASJC Scopus Subject Areas

  • Critical Care and Intensive Care Medicine

PubMed: MeSH publication types

  • Journal Article
  • Multicenter Study
  • Observational Study

Huella

Profundice en los temas de investigación de 'Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014'. En conjunto forman una huella única.

Citar esto